Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2003 2
2004 1
2005 4
2006 1
2007 3
2008 2
2009 3
2010 2
2011 6
2012 9
2013 4
2019 1
2022 0
Text availability
Article attribute
Article type
Publication date

Search Results

34 results
Results by year
Filters applied: . Clear all
Page 1
The utility of proteomics in gynecologic cancers.
Van Gorp T, Cadron I, Vergote I. Van Gorp T, et al. Among authors: cadron i. Curr Opin Obstet Gynecol. 2011 Feb;23(1):3-7. doi: 10.1097/gco.0b013e32834156e5. Curr Opin Obstet Gynecol. 2011. PMID: 21235022 Review.
Chemotherapy for recurrent cervical cancer.
Cadron I, Van Gorp T, Amant F, Leunen K, Neven P, Vergote I. Cadron I, et al. Gynecol Oncol. 2007 Oct;107(1 Suppl 1):S113-8. doi: 10.1016/j.ygyno.2007.07.004. Epub 2007 Sep 4. Gynecol Oncol. 2007. PMID: 17804044 Review.
Management of borderline ovarian neoplasms.
Cadron I, Leunen K, Van Gorp T, Amant F, Neven P, Vergote I. Cadron I, et al. J Clin Oncol. 2007 Jul 10;25(20):2928-37. doi: 10.1200/JCO.2007.10.8076. J Clin Oncol. 2007. PMID: 17617524 Review.
The management of borderline tumours of the ovary.
Cadron I, Amant F, Van Gorp T, Neven P, Leunen K, Vergote I. Cadron I, et al. Curr Opin Oncol. 2006 Sep;18(5):488-93. doi: 10.1097/01.cco.0000239889.98289.ce. Curr Opin Oncol. 2006. PMID: 16894298 Review.
Genomic aberrations relate early and advanced stage ovarian cancer.
Zaal A, Peyrot WJ, Berns PM, van der Burg ME, Veerbeek JH, Trimbos JB, Cadron I, van Diest PJ, van Wieringen WN, Krijgsman O, Meijer GA, Piek JM, Timmers PJ, Vergote I, Verheijen RH, Ylstra B, Zweemer RP; EORTC GCG Translational Research Group. Zaal A, et al. Among authors: cadron i. Cell Oncol (Dordr). 2012 Jun;35(3):181-8. doi: 10.1007/s13402-012-0077-5. Epub 2012 May 12. Cell Oncol (Dordr). 2012. PMID: 22581446 Free PMC article.
34 results